Skip to content
sellWeak

Dss, Inc. sold $88k of IBO

owner at IMPACT BIOMEDICAL INC.. 161,000 shares at an average of $0.55, traded May 22, 2025, filed Jan 6, 2026.

Warning score
26
Value
$88k
161,000 shares
Holdings after
545,024
-23% from before
From 52-week low
+38%
low $5.06, close $6.96
From 52-week high
-89%
high $62.78, as of May 22, 2025

Score components

  • Role
    10% owner
    +12
  • Trade size
    $88k at market
    +9
  • Share of holdings sold
    Sold 23% of holdings
    +5
  • Cluster
    No other insider selling within 14 days
    0

What happened after comparable sells

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

This signal so far: 1m -8.3%, 3m +26.2%, 6m -14.7%.

Price around the trade, and since

From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.

IBOOct 12, 2026 · close 4.03
Since filing Jan 6, 2026: -39.9%SPY +13.4% · excess -53.3%

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™

Rows in this filing

Every transaction in Form 4 0001493152-26-000635, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
May 22, 2025SOpen-market sale
Common Stock
-115,600$0.55$63k590,424Jan 6, 2026
May 27, 2025SOpen-market sale
Common Stock
-45,400$0.54$25k545,024Jan 6, 2026

Related signals

Other insiders at IMPACT BIOMEDICAL INC. and this insider’s other filings.

ScoreCompanyInsiderValueHoldingsFiled
12Weak
IBOsell
IMPACT BIOMEDICAL INC.
Dss, Inc.
owner
$1,686
906 shares
-0%
40Moderate
IBOsell 2
IMPACT BIOMEDICAL INC.
Todd D Macko
Chief Financial Officer
$25k
45,000 shares
-23%
34Weak
IBOsell 2
IMPACT BIOMEDICAL INC.
Jason Grady
director
$33k
50,000 shares
-17%
41Moderate
IBOsell
IMPACT BIOMEDICAL INC.
Dss, Inc.
owner
$88k
161,000 shares
-100%
54Moderate
IBOsell 2
IMPACT BIOMEDICAL INC.
Heng Fai Ambrose Chan
director
$174k
351,555 shares
-100%
63Notable
IBOsell 2
IMPACT BIOMEDICAL INC.
Dss, Inc.
owner
$845k
890,800 shares
-85%
68Notable
IBOsell 2
IMPACT BIOMEDICAL INC.
Heng Fai Ambrose Chan
director, owner
$1.1M
1,689,693 shares
-198%
68Notable
IBOsell 2
IMPACT BIOMEDICAL INC.
Heng Fai Ambrose Chan
director, owner
$2.9M
2,526,918 shares
-163%
65Notable
IBOsell 2
IMPACT BIOMEDICAL INC.
Dss, Inc.
owner
$2.0M
605,620 shares
-364%
2Weak
IBObuy
IMPACT BIOMEDICAL INC.
Dss, Inc.
owner
$310
200 shares
+0%

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Dss, Inc. sold $88k of IBO | InsiderTell